Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 25

Results For "Citi"

728 News Found

CureVac highlights shift to mRNA technology in seasonal influenza vaccine development: GlobalData
Diagnostic Center | September 19, 2023

CureVac highlights shift to mRNA technology in seasonal influenza vaccine development: GlobalData

CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology


Dr. Jitendra Singh flags off SMVD Narayana Healthcare TB Mukt Express
Healthcare | September 18, 2023

Dr. Jitendra Singh flags off SMVD Narayana Healthcare TB Mukt Express

Public private partnership (PPP) with integrated strategy essential to achieve ‘TB Mukt Bharat’ by 2025


Sun Pharma and Pharmazz ink agreement for introducing Tyvalzi in India
News | September 15, 2023

Sun Pharma and Pharmazz ink agreement for introducing Tyvalzi in India

Sun Pharma is granted rights for marketing Sovateltide in India under the brand name Tyvalzi (Sovateltide)


G20 New Delhi Leaders' Declaration on strengthening global health
Policy | September 11, 2023

G20 New Delhi Leaders' Declaration on strengthening global health

The Leaders of G20 met in New Delhi and committed to strengthening global health and implementing one health approach


Pachouli Aesthetics & Wellness launches its Faridabad Clinic
News | September 08, 2023

Pachouli Aesthetics & Wellness launches its Faridabad Clinic

Marking a significant milestone in its commitment to holistic wellness


Biocon Biologics completes integration of Viatris Biosimilars’ business in North America
News | September 07, 2023

Biocon Biologics completes integration of Viatris Biosimilars’ business in North America

Biocon Biologics recently acquired the global biosimilars business of its long-term partner Viatris


Cipla Medpro South Africa to acquire Actor Pharma
News | September 05, 2023

Cipla Medpro South Africa to acquire Actor Pharma

This is a strategic acquisition for Cipla South Africa to unlock the future growth opportunities in the South African market


Biocon acquires oral solid dosage manufacturing facility of Eywa Pharma for US$7.7 million
News | September 02, 2023

Biocon acquires oral solid dosage manufacturing facility of Eywa Pharma for US$7.7 million

The facility has a potential for capacity expansion up to 2 billion tablets/capsules per year